4Maller RA,Zhou S. Estimating the proportion of immunes in a censored sample. Biometrika, 1992,79 ( 4 ) :731-739.
5Mallet RA, Zhou S. Testing for sufficient follow-up and outliers in survival data. Journal of the American Statistical Association, 1994,89: 1499-1506.
7Laska EM, Meisner MJ. Nonparametdc estimation and testing in a cure model. Biometrics, 1992,48 (4) : 1223-1234.
8Sposto R, Sather HN, Baker SA. A comparison of testing of the difference in the proportion of patients who are cured. Biometrics, 1992,48 (1) :87-99.
9Klebanov LB, Yakovlev AY. A new approach to testing for sufficient follow-up in cure-rate analysis. Journal of Statistical Planning and - ence,2007,137 ( 11 ) : 3557-3569.
10Boag JW. Maximum likelihood estimates of the proportion of patients cured by cancer therapy. Journal of the Royal Statistical Society : Series B,1949,11:15-44.
二级参考文献26
1[1]Bang H J, Tsistis A A. Estimating medical cost with censored data.Biometrika,2000,87(2).
2[2]Cheng S C et al. Anlysis of transformation models with censored data.Biometrika, 1995, 82.
3[3]Cai J, Prentice R L, Estimating equations for hazard ratio parameters based on correlated failure time data. Biometrika, 1995, 82.
4[4]Cox D R.Regression models and life-tables.Journal of the Royal Statistical Soceity. Series B34,1972,187-220.
5[5]Dabrowska D M.Smoothed Cox regression. The Annals of Statistics,1997,25:1510-1540.
6[6]Fan J,Gijbels I. Local polynomial modeling and it's applications. Chapman & Hall,1996.
7[7]Fine J P.On association in a copula with time transformations,Biometrika,2000,87(4).
8[8]Fleming T R, Harrington D P.Counting processes and survival analysis.New York:Wiley,1991.
9[9]Huang J.Efficient Estimation for the Cox Model with Interval Censoring.Annals of Statistics,1996,24.
10[10]Huang Y J.Calibration Regression of censored lifetime medical cost.J.A.S.A,2002,97.
